EXPLAINED: 5 | Rare Historical Photos

The mineral that could protect against Alzheimer’s disease

For nearly a decade, scientists from Harvard University have also been uncovering lithium’s unexpected importance in the brain

The Independent UK · Aug 18, 2025

The vaccine that could lower the risk of dementia by 20 per cent

A new study could change the way we understand and treat dementia and other degenerative disorders of the brain

The Independent UK · Aug 8, 2025

Vaccines hold tantalizing promise in the fight against dementia

Over the past two centuries, vaccines have been critical for preventing infectious diseases. The World Health Organization estimates that vaccination prevents between 3 million and 5 million deaths annually from diseases like diphtheria, tetanus, influenza, measles and, more recently, COVID-19.

The Conversation · Aug 7, 2025

Babies have more of this Alzheimer’s-linked protein than dementia patients – study raises hope for future treatments

A protein long blamed for the brain damage seen in Alzheimer’s disease has now been found in astonishingly high levels in healthy newborn babies, challenging decades of medical dogma.

The Conversation · Jun 30, 2025

Scientists Shocked to Find Alzheimer's Biomarker in Newborn Brains: A Groundbreaking Discovery Offering Hope for Early Intervention

Scientists have discovered an Alzheimer's biomarker in newborn brains for the first time. This breakthrough could lead to earlier detection and prevention of Alzheimer's disease.

International Business Times UK · Jun 27, 2025

Breast cancer survivors may have a lower risk of Alzheimer’s disease, experts say

South Korean researchers say they had found an 8 percent lower risk

The Independent UK · Jun 20, 2025

Gut bacteria may hold key to protecting brain against Alzheimers

A bacteria best known for causing stomach ulcers could lead to a new strategy in the fight against Alzheimer’s disease

The Independent UK · Jun 19, 2025

Breakthrough Alzheimer’s drugs rejected for use on the NHS. Here’s how they work

Scientists and doctors remain divided on the targeted antibody drugs that slow down the early stages of Alzheimer’s

The Independent UK · Jun 18, 2025

Alzheimer’s drugs rejected for NHS because benefits ‘too small’ to justify cost

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s.

Evening Standard · Jun 18, 2025

How a hated bacteria could protect the brain from Alzheimer’s disease

Helicobacter pylori – a bacteria best known for causing stomach ulcers – could lead to a new strategy in the fight against Alzheimer’s disease

The Independent UK · Jun 18, 2025